UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
发明人:
CHI, Ki-Whan,지기환,JO, Jae-Ho,조재호,SONG, Young Ho,송영호,KIM, Dong-Hwan,김동환
申请号：
KRKR2015/014074
公开号：
WO2016/108489A1
申请日:
2015.12.22
申请国别(地区):
WO
年份:
2016
代理人:
摘要：
The present invention relates to: a novel tetranuclear arene-ruthenium compound, and a pharmaceutical composition for preventing or treating cancer, containing the same as an active ingredient a novel phenanthrene-ruthenium compound, and a pharmaceutical composition for preventing or treating cancer, containing the same as an active ingredient and a novel benzimidazole-ruthenium compound derived from a benzimidazolyl derivative, and a pharmaceutical composition for preventing or treating cancer, containing the same as an active ingredient.La présente invention concerne : un nouveau composé arène-ruthénium tétranucléaire et une composition pharmaceutique pour prévenir ou traiter le cancer contenant ledit composé comme principe actif un nouveau composé de phénanthrène-ruthénium et une composition pharmaceutique pour prévenir ou traiter le cancer contenant ledit composé comme principe actif et un nouveau composé de benzimidazole-ruthénium dérivé dun dérivé benzimidazolyle, et une composition pharmaceutique pour prévenir ou traiter le cancer contenant ledit composé comme principe actif.본 발명은 신규 4핵 아렌-루테늄 화합물 및 이를 유효성분으로 함유하는 암 질환 예방 또는 치료용 약학조성물에 관한 것이며, 신규한 페난트렌-루테늄 화합물 및 이를 유효성분으로 함유하는 암질환 예방 또는 치료용 약학조성물에 관한 것이며, 또한 벤즈이미다졸릴 유도체로부터 유래한 신규 벤즈이미다졸-루테늄 화합물 및 이를 유효성분으로 함유하는 암질환의 예방 또는 치료용 약학조성물에 관한 것이다.
